GNRH1 and ovarian hyperstimulation syndrome: However, the development of multiple strategies to avoid the risk of ovarian hyperstimulation syndrome, i.e., GnRH agonist trigger in GnRH antagonist protocols and the freeze-all strategy, have hindered IVM interest and progress.